The platform
Every PathCopilot module is built on the same spine — an evidence-bound drafting engine, a versioned knowledge base, a continuous eval harness, and a complete audit trail from AI call to sign-out.
Variant interpretation for hemato-oncology. AML, MDS, MPN, ALL, CLL — ELN 2022, IPSS-M, WHO 2022.
Histopathology diagnosis support. Structured reporting, pattern recognition, and guideline-based classification.
Germline interpretation & hereditary cancer risk. ACMG/AMP classification support.
How it works
01
Import a VCF or enter variants manually with karyotype and clinical context. Variants are enriched against OncoKB, ClinVar, and CIViC before drafting.
02
A structured draft is generated — per-variant tiers, risk classification, co-mutation context, therapy signals, germline flags, and citations — in seconds.
03
Edit any field inline. Every change is versioned. Sign out with a typed signature and a complete, exportable audit trail.
04
Ask the HemeCopilot assistant anything about variant classification, treatment options, or disease biology. Each response draws from the same evidence base as full interpretations — credits managed by your lab admin.
Evidence & rigor
The interpretation prompt is product code — versioned in git, changed through review, and run against an expert-validated eval set on every change. A score regression blocks the merge.
See how HemeCopilot is validated →